Announcements Trials
Browse Landscape

Phase

Phase NA 35Phase 3 4Phase 2 2Phase 4 1

Status

Unknown 2Terminated 1Recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Breast 4Head & Neck 2Gynecologic 1CNS 1

Conditions

Breast Neoplasms 4

Interventions

Cyclophosphamide 171Docetaxel 163Paclitaxel 160Trastuzumab 151Capecitabine 130Tamoxifen 119Letrozole 105Epirubicin 93Doxorubicin 83Anastrozole 83exemestane 77Fulvestrant 75Carboplatin 64Fluorouracil 63Radiotherapy 61pertuzumab 59Gemcitabine 55Vinorelbine 43Goserelin 39eribulin 36130-nm albumin-bound paclitaxel 36palbociclib 32Bevacizumab 32ribociclib 30Zoledronic Acid 29Lapatinib 29Methotrexate 28Drug Therapy 28Chemotherapy, Adjuvant 28Ado-Trastuzumab Emtansine 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Control Groups × Breast × Clear all
NCT05063136 2024-11-04

Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer

Henan Cancer Hospital

Phase 3 Recruiting
1,979 enrolled
Breast

Breast Neoplasms

NCT04385433 2023-08-24

PRAVAPREV-01

Institut du Cancer de Montpellier - Val d'Aurelle

Phase 3 Terminated
15 enrolled
Breast

Breast Neoplasms

NCT03971019 2019-08-14

SBSBC

Peking Union Medical College Hospital

Phase 3 Unknown
314 enrolled
Breast

Breast Neoplasms

NCT00582244 2007-12-28

EVA project

The Netherlands Cancer Institute

Phase 3 Unknown
325 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡